BioSig AI Sciences Receives $2.2M In Seed Funding To Advance Development Of Artificial Intelligence Applications
Portfolio Pulse from Happy Mohamed
BioSig Technologies, Inc. (NASDAQ:BSGM) has raised $2.2 million in seed funding for its subsidiary, BioSig AI Sciences, Inc. (BAIS). The funds will be used to advance the research and development of an artificial intelligence (AI) medical device platform. The market for AI in healthcare is expected to reach $272.9 billion by 2030.
July 25, 2023 | 12:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioSig Technologies has raised $2.2 million in seed funding for its subsidiary, BioSig AI Sciences. This could potentially boost the company's position in the growing AI healthcare market.
The seed funding will allow BioSig to advance the development of its AI medical device platform, potentially leading to new revenue streams and growth. Given the expected growth of the AI healthcare market, this could have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100